New Business Models for Antibiotics. What Can We Learn from Other Industries? – OHE

New solutions could emerge from incentivization models applied in other industries

ChangeThe Office of Health Economics held a workshop last year with companies that presented their business and incentivization models: BAE Systems (defence), Allianz (insurance), Barclays Bank (finance), EDF Energy (energy), Dun & Bradstreet (corporate information) and Knowledge Unlatched (academic publishing). These models were then explored further for their applicability to antibiotics R&D.

Key points & recommendations from the workshop:

– There is a need for consolidated and focused research of antibiotic R&D. “There is a need for a an entity that pools resources, science and compounds; one that is sustainable and independent with focus on the research and early development of antibiotics in line with predefined public health-need profiles. This entity should find a way to open up the science to all working in this area.”

– The creation of a global funding vehicle putting together the resources from multiple companies, academic institutions and public bodies, in order to fund the appropriate research, early development and good stewardship of antibiotics.

– The implementation of new commercial business model for antibiotics delinked from price/volume.

Find out more: New Business Models for Antibiotics

Image Source

Technology Trends Transforming Health Care – Deloitte Dbriefs Health Sciences series

Technology will drive more value, patient empowerment, care quality increase and more collaborations

eyesDeloitte top managers regularly host webcasts about health care trends. Yesterday they spoke about technology in health care and how it will transform the way we do business in this industry.

They talked about the landscape as an introduction and more specifically about 2014 digital health funding where Analytics and Big Data were one of the hottest spot together with Health care consumer engagement (see more on page 5 of the slide deck below) or by following this Rock Health link.

Big data is today unavoidable in health care. We need to manage all this amount of information in order to better care for the patients. The transformation will happen quickly as many science and technology breakthroughs are advancing faster than Moore’s law.

Deloitte spotted several trends:

Harnessing the real potential of the Internet of Things by connecting some of the available sensors and objects in order to create a chosen and deployed network.

Biosensing wearables allowing a more natural way to interact with the network to select services.

Cognitive computing augmenting human thinking for enhanced decision-making and quicker data processing.

Amplified intelligence to increase productivity of workers and helping them.

Cheap and Good Complexity. No more financial barrier for product design and customization.

Cyberdefense will be crucial with increased connectivity. Machine learning and predictive analytics will help in this field.

New roles in top management: Chief Digital Officer, Chief Data Officer, Chief Innovation Officer,… and the need of a Chief Integration Officer to promote collaboration between these functions and the more traditional responsibilities.

Technologies are fundamentally changing the health care landscape. It has implications for all the stakeholders: patients, payers, health care providers, researchers, life sciences and technology companies, governement… But in the end, it will enable the whole system to evolve toward more value (instead of volume), to empower patients/customers, to increase the quality of care and to encourage more collaborations.

Slide Deck: TechnologyTrendsTransformingHealthCare_Deloitte_April2015

Image Source